Fideuram Intesa Sanpaolo Private Banking S.P.A. Cuts Stock Holdings in Cardinal Health, Inc. $CAH

Fideuram Intesa Sanpaolo Private Banking S.P.A. lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 42.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,898 shares of the company’s stock after selling 50,501 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Cardinal Health were worth $14,559,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Norges Bank acquired a new stake in Cardinal Health during the 4th quarter worth $790,344,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Holocene Advisors LP lifted its stake in shares of Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after buying an additional 1,128,358 shares in the last quarter. Marshall Wace LLP boosted its position in Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after acquiring an additional 884,648 shares during the last quarter. Finally, Barclays PLC grew its stake in Cardinal Health by 109.3% during the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after acquiring an additional 827,446 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CAH. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 15th. Wells Fargo & Company reduced their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Evercore decreased their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a report on Wednesday, April 8th. Finally, Bank of America boosted their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $247.80.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $238.79 on Friday. The company has a market cap of $55.93 billion, a P/E ratio of 36.51, a PEG ratio of 1.17 and a beta of 0.49. The firm has a fifty day moving average of $208.22 and a two-hundred day moving average of $211.50. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $240.93.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period in the previous year, the firm earned $2.35 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s payout ratio is presently 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.